 |
|
|
|
 |
|
|
| Article 1 to 10 out of 12 concerning Harvard Medical School
|
-
Researchers use light to detect Alzheimer's
(03/18/2008)
New technique may help identify ways to predict and prevent deadly disease
A team of researchers in Bedford, Mass. has developed a way of examining brain tissue with near-infrared light to detect signs of Alzheimer's disease. In the March 15 issue of the journal Optics Letters, published by the Optical Society of America, ...
-
Acambis initiates pre-clinical testing with herpes vaccine from Harvard Medical School
(02/27/2008)
Acambis plc announced that it has initiated pre-clinical trials with a herpes vaccine, licensed from Harvard University through its Office of Technology Development, with a view to submitting an Investigational New Drug (IND) application in 2009.The ...
-
Complex Mixtures of Targeting Oligonucleotides Unlock the Power of Next-Generation DNA Sequencers
(10/22/2007)
A group of researchers at Harvard Medical School, Virginia Commonwealth University, Agilent Technologies Inc., Codon Devices Inc., and Stanford University has used complex mixtures of oligonucleotides in the form of oligonucleotide library synthesis ...
-
Chili Pepper ingredient facilitates - new pain management method
(10/08/2007)
Imagine an epidural or a shot of Novocain that doesn't paralyze your legs or make you numb, yet totally blocks your pain. This type of pain management is now within reach. As a result, childbirth, surgery and trips to the dentist might be less ...
-
Plants and stress: key players on the thin line between life and death revealed
(08/06/2007)
Our crops are not doing well these days: too much water, too little sunlight... In short, they are suffering from stress. Scientists from VIB, associated with the Katholieke Universiteit Leuven (K.U.Leuven), have revealed a new mechanism ...
-
Novavax and Collaborators Significantly Improve VLP Vaccine for HIV/AIDS
(01/18/2007)
Plans Under Way to Advance New Vaccine Into Clinical Testing
Novavax Inc. said that it has significantly enhanced both the quality and purity of its virus-like particle (VLP) vaccine for HIV/AIDS. Pre-clinical studies are under way using the improved HIV-1 vaccine, and planning has begun to advance the new ...
-
Crucell Secures $16.2 million NIH Contract for HIV Vaccine Design and Development
(10/10/2006)
Crucell N.V. announced that it has secured a US$ 16.2 million contract from the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health (NIH), for the design and development of an HIV vaccine. The ...
-
"RNAi Global" Accelerate Biomedical Discovery Using Genome-Wide siRNA Screening
(07/17/2006)
Harvard and Stanford Medical Schools and VUmc Join 12 International Research Centers and Dharmacon as Members of RNAi Global Initiative
The Genome-Wide RNAi Global Initiative (RNAi Global), an alliance of Dharmacon, Inc. and leading international research centers pioneering the use of whole-genome RNAi screening, today announced the addition of new members from Harvard Medical ...
-
Cornell and Harvard researchers discover mechanism that could lead to new treatments for Alzheimer's disease
(03/29/2006)
An enzyme previously associated with preventing the dementia of Alzheimer's disease now appears to play an even bigger role in safeguarding against the disease, bringing the promise of new targets for drug therapies.While scientists already knew ...
-
Crucell Teams up with ACE BioSciences and Harvard to Accelerate Bacterial Antibody Program
(11/04/2005)
Crucell N.V. announced that it has licensed bacterial antigens from ACE BioSciences A/S and the Brigham and Women's Hospital, a teaching hospital of Harvard Medical School, to accelerate its bacterial antibody discovery program. The bacterial ...
|
|
|
|
|
Top